Pediatrix Medical Group, Inc. (MD)

NYSE: MD · Real-Time Price · USD

25.93

-0.38 (-1.44%)

At close: Sep 28, 2026, 4:00 PM EDT

25.93

0.00 (0.00%)

After-hours: Sep 28, 2026, 6:30 PM EDT

Pediatrix Medical Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,057	1,801	1,109	770	1,217	2,319
Market Cap Growth	42.88%	62.37%	43.96%	-36.73%	-47.51%	12.69%
Enterprise Value	2,273	1,980	1,572	1,353	1,931	2,929
Last Close Price	26.31	21.39	13.12	9.30	14.86	27.21

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.36	10.89	-	-	18.35	17.71
Forward PE	10.95	9.92	8.86	7.40	8.29	16.25
PS Ratio	1.05	0.94	0.55	0.39	0.62	1.21
PB Ratio	2.37	2.08	1.45	0.91	1.37	2.59
P/FCF Ratio	8.98	7.13	6.01	7.41	8.87	52.14
P/OCF Ratio	8.32	6.64	5.37	5.61	7.29	30.23
PEG Ratio	-	0.93	1.23	1.35	0.94	0.94

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.16	1.03	0.78	0.68	0.98	1.53
EV/EBITDA Ratio	8.60	7.83	7.28	6.97	8.20	11.72
EV/EBIT Ratio	9.43	8.57	8.56	8.57	9.66	13.45
EV/FCF Ratio	9.93	7.84	8.52	13.01	14.08	65.83

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.70	0.73	0.87	0.83	0.80	1.19
Debt / EBITDA Ratio	2.25	2.35	2.69	3.10	2.67	3.82
Debt / FCF Ratio	2.71	2.51	3.59	6.75	5.23	23.96
Net Debt / Equity Ratio	0.25	0.16	0.41	0.62	0.69	0.65
Net Debt / EBITDA Ratio	0.82	0.53	1.45	2.70	2.61	2.32
Net Debt / FCF Ratio	0.94	0.53	1.70	5.04	4.47	13.01
Asset Turnover	0.92	0.87	0.92	0.87	0.78	0.63
Quick Ratio	1.28	1.62	1.43	1.18	0.94	1.88
Current Ratio	1.32	1.66	1.47	1.24	1.00	1.97
Return on Equity (ROE)	20.39%	20.28%	-12.28%	-6.94%	7.00%	13.13%
Return on Assets (ROA)	7.11%	6.57%	5.25%	4.32%	4.93%	4.48%
Return on Invested Capital (ROIC)	16.34%	16.98%	14.98%	10.97%	10.32%	12.42%
Return on Capital Employed (ROCE)	14.80%	12.90%	10.70%	8.60%	10.40%	9.50%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	8.51%	9.19%	-8.93%	-7.84%	5.45%	5.65%
FCF Yield	11.13%	14.03%	16.64%	13.50%	11.27%	1.92%
Buyback Yield / Dilution	1.21%	-2.33%	-1.37%	2.28%	1.99%	-2.92%

SEC Filings: 10-K · 10-Q